1. Home
  2. FIEE vs BNGO Comparison

FIEE vs BNGO Comparison

Compare FIEE & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiEE Inc

FIEE

FiEE Inc

HOLD

Current Price

$6.74

Market Cap

23.0M

Sector

Utilities

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.09

Market Cap

24.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIEE
BNGO
Founded
N/A
2003
Country
United States
United States
Employees
43
N/A
Industry
Telecommunications Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Utilities
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
23.0M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
FIEE
BNGO
Price
$6.74
$1.09
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
N/A
294.1K
Earning Date
N/A
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$28,720,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$24.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$1.06
52 Week High
N/A
$6.32

Technical Indicators

Market Signals
Indicator
FIEE
BNGO
Relative Strength Index (RSI) 70.58 25.96
Support Level $4.20 $1.07
Resistance Level $5.65 $1.23
Average True Range (ATR) 1.00 0.10
MACD 0.11 -0.02
Stochastic Oscillator 75.47 7.14

Price Performance

Historical Comparison
FIEE
BNGO

About FIEE FiEE Inc

FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: